In a world first, University of Ottawa scientists have introduced a metal-free MRI dye capable of mapping kidney function with unprecedented accuracy. This technique will modernize urology, allow for ...

Renal imaging utilising positron emission tomography (PET) has emerged as a powerful method in the evaluation of kidney structure and function. By harnessing radiotracers that target specific renal ...

Chronic Kidney Disease (CKD) is a major public health challenge affecting more than 10% of people. A key challenge for effective treatment is early identification of patients that are at risk of CKD ...

SAN FRANCISCO — A novel, noninvasive method was able to accurately and noninvasively identify clear cell renal carcinoma (ccRCC,), and shows promise for differentiating indeterminant renal masses, say ...

Researchers from 22 European countries have set up PARENCHIMA, a network that will boost the use of magnetic resonance imaging (MRI) biomarkers in efficiently managing chronic kidney disease. Chronic ...

I had a routine ultrasound to check my kidneys because my father (who is 80) has kidney disease, and his urologist said that ...

Niigata, Japan - The gold standard test for predicting the onset of diabetic kidney disease is albuminuria. However, detecting albuminuria alone has limited sensitivity and specificity in end-stage ...

SAN FRANCISCO—For the first time, clinicians may have an imaging tool that can help distinguish clear cell renal cell carcinoma (RCC) from other kinds of renal masses. New data from a prospective ...

"Imaging using [⁸⁹Zr]Zr-girentuximab has the potential to change clinical practice in renal cell carcinoma," write the study authors. HealthDay News — ⁸⁹Zr-labeled monoclonal antibody ...

U.S.-based researchers examined the burden of imaging in a population of patients with ADPKD, versus that of patients with chronic kidney disease (CKD). People with ADPKD underwent more abdominal ...

In a recent study, mean sensitivity was 85.5% and specificity 87% for detection of clear-cell renal cell carcinoma. (HealthDay News) — ⁸⁹Zr-labeled monoclonal antibody ([⁸⁹Zr]Zr-girentuximab) for ...